Products for Research Use Only
RegisterLogin

Canlitinib

CAT: 0804-HY-156603-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-156603-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Canlitinib is a tyrosine kinase inhibitor, extracted from patent WO2018072614 (IV-2) . Canlitinib has the potential for cancer study.
CAS Number
2222730-78-9
UNSPSC
12352005
Target
C-Met/HGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/canlitinib.html
Purity
97.0
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(CCCCCOC1=CC2=NC=CC(OC3=CC=C(NC(C4(CC4)C(NC5=CC=C(C=C5)F)=O)=O)C=C3F)=C2C=C1OC)O
Molecular Formula
C33H31F2N3O7
Molecular Weight
619.61
References & Citations
[1]Zhang, Zhiqiang, et al. Quinolinyl-substituted carboxylic acid compound or pharmaceutically acceptable salt thereof, pharmaceutical composition thereof, and use thereof. WO2017-CN104518
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-10367-01Canertinib
HY-10367A-01Canertinib (dihydrochloride)
HY-10367R-01Canertinib (Standard)
HY-10367AR-01Canertinib (dihydrochloride) (Standard)

Alternative Products

CatalogName
BA8892-1Canlitinib

Popular Products